Cannabis laws are very clear in Oklahoma. The state legalized medical cannabis in October 2018. Since then, the medical marijuana industry has boomed in Oklahoma. Notably, the industry has brought in more consumers, growers, dispensers, processors, tax revenues, and patients in the state. However, there are some challenges. A new medical marijuana law hit Oklahoma. Let’s discuss the changes.
These preliminary findings suggest that the short-term use of cannabis during chemotherapy treatment improved disease-related symptoms and did not affect cognitive skills in patients with cancer.
These preliminary findings suggest that the short-term use of cannabis during chemotherapy treatment improved disease-related symptoms and did not affect cognitive skills in patients with cancer.
Chronic pain is the leading cause of disability and is the most common cause of long-term disability
A review of the literature indicates that significant progress has been made since Dr. Ethan B. Russo’s landmark paper, just ten years ago
Abstract BACKGROUND: Medicinal cannabis registries typically report pain as the most common reason for use. It would be clinically useful to identify patterns of cannabis treatment in migraine and headache, as compared to arthritis and chronic pain, and to analyze preferred cannabis strains, biochemical profiles, and prescription medication substitutions with cannabis. METHODS: Via electronic survey in medicinal cannabis patients with headache, arthritis, and chronic pain, demographics and…
Abstract BACKGROUND: High rates of depression and anxiety have been consistently reported among patients suffering from chronic pain. Prescription opioids are one of the most common modalities for pharmacological treatment of pain, however in recent years medical marijuana(MM) has been increasingly used for pain control in the US and in several countries worldwide. The aim of…
The target dose for relieving pain in patients with malignant diseases is most likely about 10 actuations per day
Fibromyalgia might have a tremendous physical and psychological impact on patients and may lead to disability.
Abstract PURPOSE: To examine the prevalence and correlates of sleep problems in a sample of medical cannabis patients. PROCEDURES: Adults ages 21 and older (N=801,M age=45.8) who were seeking medical cannabis certification (either for the first time or as a renewal) for chronic pain at medical cannabis clinics in southern Michigan completed baseline measures of cannabis use, sleep, pain, and other related constructs.…